Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 413

1.

CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Kamide Y, Ishizuka T, Kanai Y, Nakajima T, Mori M.

Ann Surg Oncol. 2009 Dec;16(12):3473-81. doi: 10.1245/s10434-009-0685-0. Epub 2009 Sep 24.

PMID:
19777189
[PubMed - indexed for MEDLINE]
2.

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

Cancer Sci. 2009 Feb;100(2):248-54. doi: 10.1111/j.1349-7006.2008.01029.x.

PMID:
19068093
[PubMed - indexed for MEDLINE]
3.

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Nakajima T, Mori M.

Lung Cancer. 2009 Oct;66(1):120-6. doi: 10.1016/j.lungcan.2008.12.015. Epub 2009 Jan 26.

PMID:
19171406
[PubMed - indexed for MEDLINE]
4.

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.

Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

Histopathology. 2009 Jun;54(7):804-13. doi: 10.1111/j.1365-2559.2009.03300.x.

PMID:
19635099
[PubMed - indexed for MEDLINE]
5.

Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence.

Kaira K, Takahashi T, Murakami H, Shukuya T, Kenmotsu H, Naito T, Oriuchi N, Kanai Y, Endo M, Kondo H, Nakajima T, Yamamoto N.

Anticancer Res. 2011 Nov;31(11):3775-82.

PMID:
22110199
[PubMed - indexed for MEDLINE]
6.

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Kamide Y, Ishizuka T, Kanai Y, Nakajima T, Mori M.

Exp Ther Med. 2010 Sep;1(5):799-808. Epub 2010 Jul 20.

PMID:
22993604
[PubMed]
Free PMC Article
7.

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

Br J Cancer. 2008 Feb 26;98(4):742-8. doi: 10.1038/sj.bjc.6604235. Epub 2008 Feb 5.

PMID:
18253116
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

Cancer Sci. 2008 Dec;99(12):2380-6. doi: 10.1111/j.1349-7006.2008.00969.x. Epub 2008 Nov 17.

PMID:
19018776
[PubMed - indexed for MEDLINE]
9.

Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.

Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.

Cancer. 2007 Jun 15;109(12):2506-14.

PMID:
17487846
[PubMed - indexed for MEDLINE]
Free Article
10.

Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.

Donnem T, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM.

J Thorac Oncol. 2009 May;4(5):578-85. doi: 10.1097/JTO.0b013e31819f2e38.

PMID:
19318994
[PubMed - indexed for MEDLINE]
11.

Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma.

Imoto H, Osaki T, Taga S, Ohgami A, Ichiyoshi Y, Yasumoto K.

J Thorac Cardiovasc Surg. 1998 May;115(5):1007-14.

PMID:
9605068
[PubMed - indexed for MEDLINE]
12.

Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.

Han H, Silverman JF, Santucci TS, Macherey RS, d'Amato TA, Tung MY, Weyant RJ, Landreneau RJ.

Ann Surg Oncol. 2001 Jan-Feb;8(1):72-9.

PMID:
11206229
[PubMed - indexed for MEDLINE]
13.

Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.

Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Endo K, Mori M.

Cancer Sci. 2009 Apr;100(4):753-8. doi: 10.1111/j.1349-7006.2008.01077.x. Epub 2009 Jan 12.

PMID:
19141127
[PubMed - indexed for MEDLINE]
14.

Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.

Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.

Cancer. 2005 Apr 15;103(8):1676-84.

PMID:
15754326
[PubMed - indexed for MEDLINE]
Free Article
15.

Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.

Cordes C, Bartling B, Simm A, Afar D, Lautenschläger C, Hansen G, Silber RE, Burdach S, Hofmann HS.

Lung Cancer. 2009 Apr;64(1):79-85. doi: 10.1016/j.lungcan.2008.07.005. Epub 2008 Aug 29.

PMID:
18760860
[PubMed - indexed for MEDLINE]
16.

Clinical significance of IGF1R expression in non-small-cell lung cancer.

Nakagawa M, Uramoto H, Oka S, Chikaishi Y, Iwanami T, Shimokawa H, So T, Hanagiri T, Tanaka F.

Clin Lung Cancer. 2012 Mar;13(2):136-42. doi: 10.1016/j.cllc.2011.10.006. Epub 2011 Dec 1.

PMID:
22133293
[PubMed - indexed for MEDLINE]
17.

Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis.

Furuya M, Horiguchi J, Nakajima H, Kanai Y, Oyama T.

Cancer Sci. 2012 Feb;103(2):382-9. doi: 10.1111/j.1349-7006.2011.02151.x. Epub 2011 Dec 15.

PMID:
22077314
[PubMed - indexed for MEDLINE]
18.

Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.

Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.

Cancer. 2003 Jan 15;97(2):457-64.

PMID:
12518370
[PubMed - indexed for MEDLINE]
Free Article
19.

Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer.

Koh Y, Jang B, Han SW, Kim TM, Oh DY, Lee SH, Kang CH, Kim DW, Im SA, Chung DH, Kim YT, Kim TY, Kim YW, Kim JH, Heo DS, Bang YJ.

J Thorac Oncol. 2010 Mar;5(3):320-5. doi: 10.1097/JTO.0b013e3181ce684f.

PMID:
20087230
[PubMed - indexed for MEDLINE]
20.

Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.

Okada M, Sakamoto T, Yuki T, Mimura T, Nitanda H, Miyoshi K, Tsubota N.

J Thorac Cardiovasc Surg. 2005 Apr;129(4):825-30.

PMID:
15821650
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk